Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3861377 | 0.93 | KIF11 (0.60) | KIF11KCNH2 | |
| SCHEMBL4367682 | 0.92 | KIF11 (0.59) | KIF11KCNH2 | |
| Trifluoroacetic Acid SCHEMBL4376276 | 0.88 | KIF11 (0.55) | KIF11KCNH2 | |
| SCHEMBL3881801 | 0.88 | KIF11 (0.65) | KIF11KCNH2 | |
| SCHEMBL3894544 | 0.85 | KIF11 (0.56) | KIF11KCNH2 | |
| SCHEMBL3883041 | 0.85 | KIF11 (0.67) | KIF11KCNH2 | |
| SCHEMBL3863475 | 0.84 | KIF11 (0.61) | KIF11KCNH2 | |
| SCHEMBL3860346 | 0.83 | KIF11 (0.53) | KIF11KCNH2 | |
| SCHEMBL3887224 | 0.83 | KIF11 (0.53) | KIF11KCNH2 | |
| Trifluoroacetic Acid SCHEMBL4363547 | 0.82 | KIF11 (0.56) | KIF11KCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7622468-B2 | Mitotic kinesin inhibitors | MERCK & CO. INC. (US) | 2009-11-24 | — | — | US | claimed |
| EP-1581497-A4 | MITOTIC KINESIN INHIBITORS | MERCK & CO INC (US) | 2009-03-18 | — | — | EP | claimed |
| US-20060058327-A1 | Kinesin spindle protein inhibitor; antiproliferative agents; anticancer agents; 4-(2,5-difluorophenyl)-N-3-fluoropyrrolidin-3-yl)-2-hydroxymethyl-2-phenyl-2,5-diphdro-1N-pyrrol-1-carboxamide | MERCK SHARP & DOHME CORP. | 2006-03-16 | — | — | US | claimed |
| EP-1581497-A2 | MITOTIC KINESIN INHIBITORS | Merck & Co., Inc. (US) | 2005-10-05 | — | — | EP | claimed |
| WO-2004058148-A2 | MITOTIC KINESIN INHIBITORS | MERCK & CO., INC. (US) | 2004-07-15 | — | — | WO | claimed |
| US-7622468-B2 | Mitotic kinesin inhibitors | MERCK & CO. INC. (US) | 2009-11-24 | — | — | US | disclosed |
| EP-1581497-A4 | MITOTIC KINESIN INHIBITORS | MERCK & CO INC (US) | 2009-03-18 | — | — | EP | disclosed |
| US-20060058327-A1 | Kinesin spindle protein inhibitor; antiproliferative agents; anticancer agents; 4-(2,5-difluorophenyl)-N-3-fluoropyrrolidin-3-yl)-2-hydroxymethyl-2-phenyl-2,5-diphdro-1N-pyrrol-1-carboxamide | MERCK SHARP & DOHME CORP. | 2006-03-16 | — | — | US | disclosed |
| EP-1581497-A2 | MITOTIC KINESIN INHIBITORS | Merck & Co., Inc. (US) | 2005-10-05 | — | — | EP | disclosed |
| WO-2004058148-A2 | MITOTIC KINESIN INHIBITORS | MERCK & CO., INC. (US) | 2004-07-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060058327-A1 | Kinesin spindle protein inhibitor; antiproliferative agents; anticancer agents; 4-(2,5-difluorophenyl)-N-3-fluoropyrrolidin-3-yl)-2-hydroxymethyl-2-phenyl-2,5-diphdro-1N-pyrrol-1-carboxamide | KIF5B, KIF2C, KIFC1 | KIF11 10/4885KCNH2 1272/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.